Ustar Biotechnologies
Hangzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Developer of rapid point-of-care diagnostic tests for infectious diseases.
Infectious Disease
Technology Platform
Platform utilizing lateral flow immunoassay and molecular diagnostic technologies for the development of rapid point-of-care tests.
Opportunities
Significant growth potential in expanding point-of-care testing networks across Asia and other emerging markets.
Risk Factors
Heavy reliance on the competitive Chinese diagnostics market and vulnerability to pricing pressures.
Competitive Landscape
Operates in a crowded global IVD market dominated by large players like Roche and Abbott, competing on cost and local market access.